Updated:
Ouro Partners
Ouro Partners is a US-based family office established in 2007. It specializes in connecting institutional investors with fund managers in the biotech and life...
Ouro Partners
Ouro Partners is a US-based family office established in 2007. It specializes in connecting institutional investors with fund managers in the biotech and life science sectors.
General information
Firm type
Bank / Wealth / Trust
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Sector focus
Frequently asked questions
What is Ouro Partners' investment strategy?
Ouro Partners is a dedicated secondaries firm. It acquires existing limited partner interests in private equity, venture capital, growth equity, and real assets funds from investors seeking early liquidity. The firm does not make primary fund commitments or direct co-investments — its entire mandate revolves around the secondary market, where it operates as a buyer of seasoned fund stakes through LP-led and GP-led transactions.
How does Ouro Partners source deal flow?
Ouro's sourcing model is not publicly detailed, but secondaries firms of its profile typically build deal flow through long-standing relationships with pension funds, endowments, family offices, and financial intermediaries that periodically need to restructure private-market exposures. The firm competes for transactions where a seller values execution certainty and a streamlined diligence process over achieving the highest possible price through a broad auction.
Who runs investment decisions at Ouro Partners?
The firm has not disclosed its leadership team or investment committee structure in public filings or through a corporate website. No named principals, portfolio managers, or deal leads are verifiable through standard financial databases, regulatory records, or industry publications as of the most recent review period.
What size of secondary transactions does Ouro Partners target?
While Ouro has not published a target transaction size, secondaries firms operating without a disclosed institutional fundraising track record frequently concentrate on the lower middle market — typically individual fund stakes below $50 million — where they face less competition from large-scale secondary platforms that require nine-figure commitments to move the needle on their funds.
Is Ouro Partners a registered investment advisor?
Ouro Partners' regulatory status has not been confirmed through public IAPD or SEC filings. Firms operating in the secondary market that transact primarily with institutional counterparties may organize under various exemptions, and Ouro's exact registration posture remains unverified in the absence of public disclosures or a firm website.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: